VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 51 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,014,451 | -25.8% | 646,945 | +9.6% | 0.00% | 0.0% |
| Q2 2023 | $6,758,419 | +220.8% | 590,255 | +116.0% | 0.00% | – |
| Q1 2023 | $2,106,796 | +126586.5% | 273,255 | +0.2% | 0.00% | – |
| Q4 2022 | $1,663 | -99.9% | 272,738 | +0.6% | 0.00% | – |
| Q3 2022 | $1,604,000 | +0.3% | 271,022 | +0.1% | 0.00% | – |
| Q2 2022 | $1,599,000 | -20.4% | 270,722 | +2.7% | 0.00% | – |
| Q1 2022 | $2,009,000 | +110.8% | 263,697 | -25.1% | 0.00% | – |
| Q4 2021 | $953,000 | +30.2% | 351,964 | +26.3% | 0.00% | – |
| Q3 2021 | $732,000 | -36.2% | 278,646 | +0.2% | 0.00% | – |
| Q2 2021 | $1,148,000 | -47.6% | 278,126 | -40.2% | 0.00% | – |
| Q1 2021 | $2,189,000 | -21.8% | 464,818 | +18.7% | 0.00% | – |
| Q4 2020 | $2,799,000 | -33.9% | 391,656 | -1.3% | 0.00% | -100.0% |
| Q3 2020 | $4,232,000 | -17.2% | 396,643 | -2.1% | 0.00% | 0.0% |
| Q2 2020 | $5,111,000 | +41.0% | 405,004 | +2.2% | 0.00% | 0.0% |
| Q1 2020 | $3,626,000 | -66.1% | 396,316 | -48.4% | 0.00% | 0.0% |
| Q4 2019 | $10,704,000 | +63.5% | 767,350 | +101.7% | 0.00% | -50.0% |
| Q3 2019 | $6,547,000 | -34.9% | 380,448 | +3.0% | 0.00% | 0.0% |
| Q2 2019 | $10,050,000 | +65.8% | 369,229 | +16.5% | 0.00% | 0.0% |
| Q1 2019 | $6,063,000 | +12.3% | 316,803 | -44.9% | 0.00% | +100.0% |
| Q4 2018 | $5,400,000 | +22.3% | 574,528 | +146.2% | 0.00% | 0.0% |
| Q3 2018 | $4,415,000 | -3.1% | 233,376 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $4,557,000 | +29.3% | 233,224 | +24.3% | 0.00% | 0.0% |
| Q1 2018 | $3,524,000 | +23.0% | 187,582 | +8.6% | 0.00% | 0.0% |
| Q4 2017 | $2,866,000 | -1.5% | 172,673 | +22.1% | 0.00% | 0.0% |
| Q3 2017 | $2,911,000 | +377.2% | 141,425 | +107.5% | 0.00% | – |
| Q2 2017 | $610,000 | -26.2% | 68,160 | +9.1% | 0.00% | – |
| Q1 2017 | $827,000 | +12.1% | 62,485 | +7.8% | 0.00% | – |
| Q4 2016 | $738,000 | +11.0% | 57,969 | +4.7% | 0.00% | – |
| Q3 2016 | $665,000 | +13.3% | 55,385 | +3.7% | 0.00% | – |
| Q2 2016 | $587,000 | +28.2% | 53,432 | +1.8% | 0.00% | – |
| Q1 2016 | $458,000 | -52.4% | 52,472 | +19.3% | 0.00% | -100.0% |
| Q4 2015 | $963,000 | – | 43,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |